Crossmark

Comparative analysis between the use of renin–angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection

Crossref DOI link: https://doi.org/10.1016/j.medcle.2020.07.013

Published Print: 2020-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Martínez-del Río, Jorge

Piqueras-Flores, Jesús

Nieto-Sandoval Martín de la Sierra, Patricia

Negreira-Caamaño, Martín

Águila-Gordo, Daniel

Mateo-Gómez, Cristina

Salas-Bravo, Daniel

Rodríguez-Martínez, Marta
License Information

Text and Data Mining valid from 2020-12-01
More Information

This article is maintained by: Elsevier

Article Title: Comparative analysis between the use of renin–angiotensin system antagonists and clinical outcomes of hospitalized patients with COVID-19 respiratory infection

Journal Title: Medicina Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcle.2020.07.013

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.medcli.2020.07.004

Content Type: article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below